70 studies found for:    peanut allergy
Show Display Options
Download search resultsDownload the search results for:
peanut allergy (70 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Not yet recruiting Boiled Peanut Oral Immunotherapy for the Treatment of Peanut Allergy: a Pilot Study
Condition: IgE Mediated Peanut Allergy
Interventions: Other: Desensitisation using boiled peanut;   Other: Desensitisation using boiled peanut (deferred start)
2 Active, not recruiting Oral Immunotherapy (OIT) for Peanut Allergy
Condition: Peanut Hypersensitivity
Interventions: Drug: Peanut flour;   Drug: Subjects will receive oral oat flour.
3 Unknown  A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy
Conditions: Peanut Hypersensitivity;   Food Hypersensitivity;   Immediate Hypersensitivity
Interventions: Drug: Peanut powder;   Drug: Peanut extract;   Drug: Placebo extract;   Drug: Placebo powder
4 Unknown  Peanut Allergy Oral Immunotherapy Desensitization
Condition: Peanut Allergy
Interventions: Procedure: Peanut protein;   Procedure: Oat flour
5 Withdrawn Efficacy and Safety of 4 Doses of QGE031 in Patients 18-50 Years of Age With Peanut Allergy
Condition: Peanut Allergy
Interventions: Drug: QGE031;   Drug: Placebo
6 Active, not recruiting Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Condition: Peanut Allergy
Interventions: Biological: Viaskin Peanut 50 mcg;   Biological: Viaskin Peanut 100 mcg;   Biological: Viaskin Peanut 250 mcg;   Biological: Viaskin Placebo
7 Active, not recruiting Epicutaneous Immunotherapy in Peanut Allergy in Children
Condition: Peanut Allergy
Interventions: Biological: Epicutaneous Immunotherapy;   Biological: placebo of peanut
8 Active, not recruiting Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy
Condition: Peanut Hypersensitivity
Interventions: Drug: Peanut Oral Immunotherapy;   Drug: Omalizumab
9 Active, not recruiting Mucosal Immunotherapy for Peanut Allergy
Condition: Food Hypersensitivity
Interventions: Biological: Peanut flour;   Biological: Oat
10 Completed Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults
Conditions: Food Hypersensitivity;   Hypersensitivity;   Immediate Hypersensitivity;   Peanut Hypersensitivity
Intervention: Biological: E. Coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3
11 Unknown  Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization
Condition: Peanut Allergies in Children
Intervention: Drug: Ketotifen
12 Recruiting HAL-MPE1 First-in-human
Condition: Peanut Allergy
Interventions: Drug: HAL-MPE1;   Drug: Placebo
13 Active, not recruiting
Has Results
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
Conditions: Food Hypersensitivity;   Hypersensitivity;   Immediate Hypersensitivity;   Peanut Hypersensitivity
Interventions: Drug: Glycerinated peanut allergenic extract;   Drug: Placebo for peanut extract (glycerin)
14 Active, not recruiting Peanut Epicutaneous Immunotherapy
Conditions: Peanut Hypersensitivity;   Food Hypersensitivity;   Hypersensitivity;   Hypersensitivity, Immediate
Interventions: Biological: 250 microgram (mcg) DBV712 Viaskin Patch;   Biological: 100 microgram DBV712 Viaskin Patch;   Biological: Placebo Viaskin Patch
15 Not yet recruiting Reduction of Peanut Reactivity and Immune Modulation With Anti-IgE Therapy
Conditions: Peanut Allergy;   Allergic/Atopic Individuals;   Non Allergic Individuals;   Allergic Individuals Receiving Xolair Therapy
Intervention:
16 Active, not recruiting The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy
Condition: Peanut Allergy
Intervention: Drug: Peanut Dissolving Film
17 Completed Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
Condition: Peanut Allergy
Interventions: Biological: Whole peanut extract;   Biological: Placebo formulation
18 Completed Immunotherapy for Peanut Allergy
Condition: Allergy
Intervention: Procedure: Sublingual immunotherapy
19 Unknown  Omalizumab in the Treatment of Peanut Allergy
Conditions: Food Allergy;   Peanut Allergy
Intervention: Drug: omalizumab
20 Active, not recruiting Oral Peanut Immunotherapy
Condition: Peanut Allergy
Intervention: Drug: Peanut flour OIT

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years